Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTAGE family member 11, pseudogene (CTAGE11P) is a human processed pseudogene located on chromosome 13; it does not encode a protein and is not considered a functional receptor, enzyme, or direct therapeutic target[1][3][5]. Like other pseudogenes, it is the remnant of a once-functional gene, now rendered non-coding due to mutations or deletions[2][4]. While some human pseudogenes can participate in gene regulation by affecting host gene expression or acting through RNA transcripts, no specific biological function, disease association, or therapeutic relevance has been described for CTAGE11P[1][3][5]. Summary: CTAGE11P should not be considered a target for drug development or therapeutic intervention. It is correctly classified as a pseudogene, not a receptor or drug target, and therefore most fields requested here are not applicable for CTAGE11P[1][3][5].
None (No mechanism, as no drugs or molecules are known to act on CTAGE11P)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTAGE family member 11, pseudogene (CTAGE11P).